Skip to main content
Veterinary Medicines

SPECTOLIKEL 50/100 mg/ml solution for injection for calves, sheep and pigs

Authorised
  • Spectinomycin
  • Lincomycin

Product identification

Medicine name:
SPECTOLIKEL 50/100 mg/ml solution for injection for calves, sheep and pigs
Spectoliphen 50 mg/ml Oplossing voor injectie voor kalveren, schapen en varkens
Spectoliphen 50 mg/ml Solution injectable pour veaux, ovins et porcins
Spectoliphen 50 mg/ml Injektionslösung für Kälber, Schafe und Schweine
Active substance:
  • Spectinomycin
  • Lincomycin
Target species:
  • Sheep
  • Pig
  • Cattle
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Spectinomycin
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Lincomycin
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Sheep
      • Meat and offal
        15
        day
    • Pig
      • Meat and offal
        14
        day
    • Cattle
      • Meat and offal
        23
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF52
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Available in:
  • Belgium
Package description:
  • 250 ml translucent polypropylene vials, with bromobutyl stopper and aluminium cap with FLIP-OFF seal.
  • 100 ml translucent polypropylene vials, with bromobutyl stopper and aluminium cap with FLIP-OFF seal.
  • 6x250 ml translucent polypropylene vials, with bromobutyl stopper and aluminium cap with FLIP-OFF seal.
  • 10X100 ml translucent polypropylene vials, with bromobutyl stopper and aluminium cap with FLIP-OFF seal.

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • KELA Kempisch Laboratorium Kela Laboratoria
Marketing authorisation date:
Manufacturing sites for batch release:
  • S P Veterinaria S.A.
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V445137
Date of authorisation status change:
Reference member state:
  • Portugal
Procedure number:
  • PT/V/0111/001
Concerned member states:
  • Belgium

Documents

Summary of Product Characteristics

English (PDF)
Published on: 6/01/2026
Download
Dutch (PDF)
Published on: 8/01/2026
French (PDF)
Published on: 8/01/2026

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 8/01/2026
French (PDF)
Published on: 8/01/2026
German (PDF)
Published on: 8/01/2026

Labelling

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 8/01/2026
French (PDF)
Published on: 8/01/2026
German (PDF)
Published on: 8/01/2026